- Home
- TWFG vs RXST Comparison
TWFG vs RXST Comparison
Compare TWFG & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWFG
- RXST
- Stock Information
- Founded
- TWFG 2001
- RXST 1997
- Country
- TWFG United States
- RXST United States
- Employees
- TWFG N/A
- RXST N/A
- Industry
- TWFG
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TWFG
- RXST Health Care
- Exchange
- TWFG NYSE
- RXST Nasdaq
- Market Cap
- TWFG 521.8M
- RXST 553.1M
- IPO Year
- TWFG 2024
- RXST 2021
- Fundamental
- Price
- TWFG $33.19
- RXST $8.03
- Analyst Decision
- TWFG Buy
- RXST Hold
- Analyst Count
- TWFG 8
- RXST 11
- Target Price
- TWFG $35.57
- RXST $19.40
- AVG Volume (30 Days)
- TWFG 123.5K
- RXST 1.8M
- Earning Date
- TWFG 08-26-2025
- RXST 08-07-2025
- Dividend Yield
- TWFG N/A
- RXST N/A
- EPS Growth
- TWFG N/A
- RXST N/A
- EPS
- TWFG N/A
- RXST N/A
- Revenue
- TWFG $211,440,000.00
- RXST $148,310,000.00
- Revenue This Year
- TWFG $23.90
- RXST $17.41
- Revenue Next Year
- TWFG $22.60
- RXST $12.44
- P/E Ratio
- TWFG N/A
- RXST N/A
- Revenue Growth
- TWFG 18.57
- RXST 46.70
- 52 Week Low
- TWFG $21.31
- RXST $6.32
- 52 Week High
- TWFG $36.85
- RXST $58.23
- Technical
- Relative Strength Index (RSI)
- TWFG N/A
- RXST 21.66
- Support Level
- TWFG N/A
- RXST $6.32
- Resistance Level
- TWFG N/A
- RXST $8.50
- Average True Range (ATR)
- TWFG 0.00
- RXST 0.77
- MACD
- TWFG 0.00
- RXST -0.52
- Stochastic Oscillator
- TWFG 0.00
- RXST 21.50
About TWFG TWFG INC
TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.